A carregar...

149. Effect of Lurasidone on Quality of Life, Function, and Metabolic Parameters in Adolescent Patients With Schizophrenia: Results From a 6-Week, Double-Blind, Placebo-Controlled Study

Background: Several atypical antipsychotics are approved to treat adolescent patients with schizophrenia. However, risk for antipsychotic-associated weight gain and metabolic dysfunction underscores the need to identify additional evidence-based treatments that are both efficacious and well tolerate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Schizophr Bull
Main Authors: Findling, Robert, Goldman, Robert, Cucchiaro, Josephine, Deng, Ling, Loebel, Antony
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475665/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbx021.207
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!